The Priority Review

Tag

Stress urinary incontinence

1 story

Stories

  1. Clinical trials

    Pfizer registers Phase 3 trial of berobenatide in women with stress urinary incontinence and obesity

    The study, titled VESPER-SUI, plans to enroll 900 participants and has a planned start date of November 17, 2026. It aims to learn about the safety and effectiveness of berobenatide in adult women with stress urinary incontinence and obesity or overweight.